Orphan CYPs: homing In
April 13, 2022 8:48 am Leave your thoughtsOrphan CYPs – finding a home in personalised medicine By Samuel Coe Cytochrome P450 enzymes (CYPs) are responsible for the...
View Article
Orphan CYPs – finding a home in personalised medicine By Samuel Coe Cytochrome P450 enzymes (CYPs) are responsible for the...
View Article
The underappreciated hydroxyl in drug discovery By Rob Young Here we explore some of the potential impacts of hydroxyl groups...
View Article
Q1 2022 Newsletter – API degradation products and steroid metabolism Our new service for accessing API degradation products and impurities...
View Article
Today’s Medicinal Chemist – a checklist for Candidate selection By Steve Djuric Many (many) years ago as a fledgling medicinal...
View Article
De-risking DMPK: what’s key? By Guy Webber Drugs can fail i) before they enter clinical development in humans ii) during...
View Article
CYP2J2: An epoxygenase worth bothering about? By Julia Shanu-Wilson CYP2J2 snuck into last place in the breakdown by Zanger and...
View Article
Q4 2021 Newsletter – Metabolite identification by PolyCYPs and 20% off Kit Offer Metabolite identification by PolyCYPs – in our...
View Article
We discuss the synthesis of deuterated metabolites and purification of metabolites from complex mixtures in our Q2 2021 technical newsletter....
View Article
LipMetE – A useful tool for relating lipophilicity to metabolic stability in microsomes? By Samuel Coe LipMetE is a potentially...
View Article
Metabolism of cyclopropyl groups: a double-edged sword By Julia Shanu-Wilson Cyclopropyl groups are an appealing substituent to use in drug...
View Article